In a recent announcement, UE LifeSciences, a medical device company, has assigned its social media mandate to Digitales PR Medios. The account was won post a multi-agency pitch.
Ranjan Kumar, director, Digitales PR Medios, says in a press release, "Breast cancer awareness is a topic that everyone knows about and is also concerned about, but what happens after is a completely different story from our initial concern. In the current times that we are living in, there is a high chance of breast cancer. The risk of breast cancer cannot be taken lightly by anyone. Taking an early breast cancer detection exam is a must and to add to that, awareness about breast cancer is a must not just for the female audience but for the males as well. They should make sure their mother, wife, sister or friend don't take any symptoms lightly."
He adds, "When the brief came to us about iBreastExam, we were thrilled as it posed a challenging task - to convince the audience, through digital channels, to opt for early breast cancer detection. The product which they have developed is simply marvellous. Imagine the number of lives that could be saved with such an amazing innovation. We latched on to it quickly and made a point to make it as visible on digital platforms as we could. A digital innovation like iBreastExam is kind of a perfect match for a digital creative agency like ours; in fact, it's the safest bet for the brand, if we can say."
Iftekhar Ahmed, head of marketing, UE LifeSciences, says in a press release, "The Pharma and medical industry are not untouched by the digital revolution and we are well aware of its disruptive potential. Our product, iBreastExam, is itself an innovative and revolutionary product. With Digitales we want to transform how marketing can reach-out globally, tell a story effectively, engage, and get better value of digital initiatives."